BlackRock Advisors’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$33K Hold
1,320
﹤0.01% 3353
2016
Q3
$26K Sell
1,320
-1,104
-46% -$20.5K ﹤0.01% 3395
2016
Q2
$33K Hold
2,424
﹤0.01% 3330
2016
Q1
$33K Hold
2,424
﹤0.01% 3298
2015
Q4
$25K Hold
2,424
﹤0.01% 3434
2015
Q3
$24K Buy
2,424
+623
+35% +$7.26K ﹤0.01% 3473
2015
Q2
$27K Hold
1,801
﹤0.01% 3429
2015
Q1
$30K Hold
1,801
﹤0.01% 3364
2014
Q4
$27K Hold
1,801
﹤0.01% 3429
2014
Q3
$26K Hold
1,801
﹤0.01% 3439
2014
Q2
$26K Hold
1,801
﹤0.01% 3384
2014
Q1
$31K Hold
1,801
﹤0.01% 3331
2013
Q4
$26K Buy
1,801
+217
+14% +$2.99K ﹤0.01% 3348
2013
Q3
$21K Hold
1,584
﹤0.01% 3313
2013
Q2
$17K Buy
+1,584
New +$17.8K ﹤0.01% 3301

Other funds holding PMD

BlackRock Advisors's PMD Position: Q4 2016 in Review

BlackRock Advisors held its Psychemedics Corporation (PMD) position steady in Q4 2016 at 1,320 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3353.

BlackRock Advisors first reported a position in PMD in Q2 2013 and has held it in 15 quarters since. 52 funds tracked by Wall St. Rank hold PMD as of Q4 2016.

  • BlackRock Advisors held 1,320 shares of Psychemedics Corporation worth $33K as of Q4 2016.
  • BlackRock Advisors left its Psychemedics Corporation share count unchanged in Q4 2016.
  • Psychemedics Corporation made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3353 holding.
  • BlackRock Advisors first reported a position in Psychemedics Corporation in Q2 2013 and has held it in 15 quarters since.
  • 52 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.